Topics
News
CME/CE
Editorial Advisory Board
Partnerships
- Dry Cracked Skin
- Impetigo
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Surgery
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Inflamed Skin
Use of Spesolimab in the Treatment of GPP
Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.
EP: 1.Overview of Generalized Pustular Psoriasis and Diagnosis Considerations
EP: 2.Burden and QoL Impacts on GPP
EP: 3.Discussion of Traditional and Novel GPP Treatment Modalities
EP: 4.Approaches to a Generalized Pustular Psoriasis Diagnosis (GPP)
EP: 5.Current Treatments in GPP
Now Viewing
EP: 6.Use of Spesolimab in the Treatment of GPP
EP: 7.Expert Insight of Generalized Pustular Psoriasis
EP: 8.Role of Current Treatments in GPP
EP: 9.Educational and Unmet Needs in GPP Management
Related Videos
Related Content
